Letter: L.A.T.S. and Graves' disease.
作者信息
Volpé R, Farid N R, Von Westarp C, Row V V
出版信息
Lancet. 1974 Oct 5;2(7884):843. doi: 10.1016/s0140-6736(74)91107-6.
PMID:4138250
Abstract
摘要
相似文献
1
Letter: L.A.T.S. and Graves' disease.信函：L.A.T.S.与格雷夫斯病
Lancet. 1974 Oct 5;2(7884):843. doi: 10.1016/s0140-6736(74)91107-6.
2
Ophthalmic Graves' disease. Diagnosis and pathogenesis.眼科格雷夫斯病。诊断与发病机制。
Lancet. 1970 Feb 21;1(7643):375-8. doi: 10.1016/s0140-6736(70)91513-8.
3
Humoral immunity in Graves' disease.格雷夫斯病中的体液免疫。
Clin Endocrinol Metab. 1978 Mar;7(1):31-45. doi: 10.1016/s0300-595x(78)80034-6.
4
The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).长效甲状腺刺激素（LATS）水平高的格雷夫斯病患者甲状腺放射性消融的效果。
Am J Med. 1969 Feb;46(2):217-26. doi: 10.1016/0002-9343(69)90006-0.
5
6
Letter: Thyroid-stimulating immunoglobulins.信函：促甲状腺素受体抗体
Lancet. 1975 Apr 19;1(7912):918. doi: 10.1016/s0140-6736(75)91716-x.
7
[LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].[促甲状腺素（LATS）——垂体外甲状腺刺激素及其在格雷夫斯-巴塞多病病因学和发病机制中的作用]
Pol Arch Med Wewn. 1969 Oct;43(4):1427-32.
8
Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.血浆长效甲状腺刺激素和甲状腺抗体水平，以及格雷夫斯病的临床表现。
Acta Med Acad Sci Hung. 1969;26(3):233-43.
9
Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.长效甲状腺刺激素与甲状腺微粒体抗体之间的关系。
J Endocrinol. 1969 Jan;43(1):125-6. doi: 10.1677/joe.0.0430125.
10
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease.非甲状腺肿瘤性疾病行颈部外照射后发生的格雷夫斯眼病。
J Clin Endocrinol Metab. 1973 Nov;37(5):703-13. doi: 10.1210/jcem-37-5-703.
Zotero 插件